Updated Jul 16, 2026
Mandelia Ashish is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $16K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-10-07 | MRSN | Mersana Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.4K | $1.96 | $7K |
| 2024-10-07 | MRSN | Mersana Therapeutics, Inc. | S — Open-market sale [10b5-1] | 4.9K | $2.00 | $10K |
| 2024-10-07 | MRSN | Mersana Therapeutics, Inc. | M — Option exercise [10b5-1] | 30.0K | $0.00 |
Mandelia Ashish is a corporate insider — currently tracked as VP, Chief Accounting Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($16K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mandelia Ashish profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.